SEC 8-K
SEC 8-K: Item 3.01, 7.01, 9.01
Official SEC filing update. Items: 3.01, 7.01, 9.01.
Item 3.01, 7.01, 9.01Accession 0001104659-25-100618
Official SEC filings
Adaptimmune Therapeutics PLC SEC Filings and Updates
A filing-level feed of official SEC EDGAR updates collected by Billiver. This page shows metadata and source links only; full filing text opens on SEC.gov.
Adaptimmune Therapeutics PLC Official SEC Updates
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Open SEC filing
SEC 8-K
SEC 8-K: Item 3.01
Official SEC filing update. Items: 3.01.
Item 3.01Accession 0001104659-25-093882
SEC 8-K
SEC 8-K: Item 3.01
Official SEC filing update. Items: 3.01.
Item 3.01Accession 0001104659-25-089558
SEC 8-K
SEC 8-K: Item 5.02, 9.01
Official SEC filing update. Items: 5.02, 9.01.
Item 5.02, 9.01Accession 0001558370-25-011925
SEC 8-K
SEC 8-K: Item 5.02, 9.01
Official SEC filing update. Items: 5.02, 9.01.
Item 5.02, 9.01Accession 0001558370-25-011820
SEC 8-K
SEC 8-K: Item 5.02, 9.01
Official SEC filing update. Items: 5.02, 9.01.
Item 5.02, 9.01Accession 0001558370-25-011616
SEC 8-K
SEC 8-K: Item 3.01
Official SEC filing update. Items: 3.01.
Item 3.01Accession 0001558370-25-011579
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001558370-25-011307
SEC 8-K
SEC 8-K: Item 2.02, 9.01
Official SEC filing update. Items: 2.02, 9.01.
Item 2.02, 9.01Accession 0001558370-25-011304
SEC 8-K
SEC 8-K: Item 5.02, 9.01
Official SEC filing update. Items: 5.02, 9.01.
Item 5.02, 9.01Accession 0001558370-25-010785
SEC 8-K
SEC 8-K: Item 1.02, 2.01, 9.01
Official SEC filing update. Items: 1.02, 2.01, 9.01.
Item 1.02, 2.01, 9.01Accession 0001104659-25-072753
SEC 8-K
SEC 8-K: Item 1.01, 2.05, 5.02, 7.01, 9.01
Official SEC filing update. Items: 1.01, 2.05, 5.02, 7.01, 9.01.
Item 1.01, 2.05, 5.02, 7.01, 9.01Accession 0001104659-25-071009
SEC 8-K
SEC 8-K: Item 8.01
Official SEC filing update. Items: 8.01.
Item 8.01Accession 0001558370-25-009278
SEC 8-K
SEC 8-K: Item 5.07
Official SEC filing update. Items: 5.07.
Item 5.07Accession 0001104659-25-054232
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001558370-25-007571
Source: SEC EDGAR · 15 filings
Informational only. Not investment advice.